Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ANP32BP2 encodes a pseudogene related to Acidic nuclear phosphoprotein 32 family member B (ANP32B). Pseudogenes are non-functional segments of DNA that resemble normal genes but are generally not transcribed or translated into functional proteins. ANP32BP2 does not encode a protein, is not a receptor, enzyme, or transporter, and is not considered a therapeutic or molecular target. There is no evidence for a biological function, role in disease, interaction with drugs, or biomarker utility. It is listed in gene databases like GeneCards as a pseudogene and not as a functional protein-coding or regulatory gene[7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acidic nuclear phosphoprotein 32 family member B pseudogene 2 (ANP32BP2).